HEXSEL DORIS MARIA has a total of 11 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and consumer goods are KADE PHARMA FAB GMBH, SUNOVION RESPIRATORY DEV INC and GALEPHAR M F.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Consumer goods | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics | |
#4 | Protective garments | |
#5 | Live-saving devices | |
#6 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Hexsel Doris Maria | 11 |
#2 | De Oliveira Dal'Forno Dini Taciana | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019018912A1 | Humidifying and protective arrangement applied to a mask | |
WO2018023183A1 | Clothing for combating loss of muscle tone | |
WO2018000067A1 | Use of an active substance in the treatment of telangiectatic melasma | |
WO2018014098A1 | Use of pharmaceutical composition for the treatment of skin erythema in periorbital dark circles | |
EP3434271A1 | Use of pharmaceutical composition for the treatment of poikiloderma of civatte | |
BR102016015213A2 | use of an active substance in the treatment of telangiectatic melasma |